195 related articles for article (PubMed ID: 582751)
21. [Multi-center study of Cetal retard. Results of 60 studies].
Jeske H; Lehrl S; Rudschies H; Schulte-Steinberg G
ZFA (Stuttgart); 1982 Mar; 58(7):430-8. PubMed ID: 7090516
[No Abstract] [Full Text] [Related]
22. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
Petruzzi E; Bucalossi A
Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
[No Abstract] [Full Text] [Related]
23. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
Linquette M
Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
[No Abstract] [Full Text] [Related]
25. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
Borzeix MG; Cahn J
Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic study of vincamine teprosilate.
Cadórniga R; Saiz Vadillo MC; Molina IT; Cadórniga L
Int J Clin Pharmacol Res; 1984; 4(4):281-90. PubMed ID: 6500775
[TBL] [Abstract][Full Text] [Related]
27. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
Schenker H
Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
[No Abstract] [Full Text] [Related]
28. [Clinical and electrophysiologic changes produced by (--) eburnamonine in acute and post-acute stages of head injuries].
Facciolla D; Ruocco A; Rossi A; Serra C; Bufalino L; Cavrini P
Riv Neurol; 1983; 53(1):15-33. PubMed ID: 6857109
[TBL] [Abstract][Full Text] [Related]
29. [The effect of vincamine on cerebral blood flow as a function of application rate (author's transl)].
Heiss WD; Podreka I; Samec P
Arzneimittelforschung; 1977; 27(6a):1291-3. PubMed ID: 578455
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
Bartels H
Med Klin; 1979 Oct; Suppl():46-7. PubMed ID: 542167
[No Abstract] [Full Text] [Related]
31. [Vincamine concentrations in plasma and cerebrospinal fluid in patients following intravenous infusion (author's transl)].
Siegers CP; Heiss WD; Kohlmeyer K
Arzneimittelforschung; 1977; 27(6a):1274-7. PubMed ID: 578452
[TBL] [Abstract][Full Text] [Related]
32. [Plasma concentrations and renal excretion of vincamine after oral administration in man (author's transl)].
Siegers CP; Iven H; Strubelt O
Arzneimittelforschung; 1977; 27(6a):1271-4. PubMed ID: 578451
[TBL] [Abstract][Full Text] [Related]
33. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
Steinhäuser B
Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
[No Abstract] [Full Text] [Related]
34. [Effects of a vincamine-papaverine combination on platelet aggregation in geriatric patients with glucose and/or lipid metabolism disorders].
Petruzzi E; Bucalossi A; Chiostri R
Minerva Cardioangiol; 1985 Sep; 33(9):561-4. PubMed ID: 4088484
[No Abstract] [Full Text] [Related]
35. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
Martucci N; Manna V; Agnoli A
Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
[TBL] [Abstract][Full Text] [Related]
36. [Demonstrating the effectiveness of cerebroactive drugs in aged patients. Results of a randomized double-blind study of a vincamine containing special preparation].
Foltyn P; Groh R; Lücker PW; Steinhaus W
Arzneimittelforschung; 1978; 28(1):90-4. PubMed ID: 343787
[TBL] [Abstract][Full Text] [Related]
37. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
[No Abstract] [Full Text] [Related]
38. [Severe ventricular arrhythmia following parenteral administration of vincamine. Predisposing factors in 6 cases].
Dany F; Liozon F; Goudoud JC; Castel JP; Michel JP; Marsaud P; Merle L; Dallocchio M
Arch Mal Coeur Vaiss; 1980; 73(3):298-306. PubMed ID: 6779745
[TBL] [Abstract][Full Text] [Related]
39. [Cerebroxine and the treatment of sudden deafness. Apropos of 2 representative cases].
Van Geert G; Hennebert D
Brux Med; 1979; 59(11-12):515-23. PubMed ID: 534950
[No Abstract] [Full Text] [Related]
40. Studies on the vincamine-papaverine association. VI. Interference with alpha receptors. Preliminary clinical evidence.
Pedini G; Costa G; Bossi M; Manani G
Agressologie; 1979; 20(4):221-3. PubMed ID: 233544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
